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Abstract
Aim Strain elastography is a method for recording tissue
hardness. Strain in different areas may be compared using
strain ratio (SR). The aims of this study were to validate a
previously proposed SR cut-off value of 1.25 for differen-
tiating adenocarcinomas from adenomas and to compare
the performance of endorectal ultrasonography (ERUS),
strain elastography and MRI in the same patients.
Method A prospective evaluation of 120 consecutive
patients with rectal neoplasia, using a predetermined
elastography strain ratio cut-off value, was performed to
differentiate adenomas from adenocarcinomas. ERUS
and MRI were performed according to standard routine
at Haukeland University Hospital, defining T0 as ade-
nomas and T1–T4 as adenocarcinomas. Subsequent his-
topathology was used as the reference standard.
Results Histopathological evaluation revealed 21 ade-
nomas and 99 adenocarcinomas. Sensitivity, specificity
and accuracy (with 95% CI) were as follows: ERUS:
0.96 (0.90–0.99), 0.62 (0.40–0.80) and 0.90 (0.83–
0.94); elastography SR: 0.96 (0.90–0.99), 0.86 (0.66–
0.96) and 0.94 (0.88–0.97); and MRI: 0.99 (0.94–
1.00), 0.07 (0.00–0.31) and 0.87 (0.80–0.93).
Conclusion This study confirms that the elastography
SR assessment accurately differentiates sessile adenomas
from adenocarcinomas. SR assessment has a superior
ability to differentiate adenomas and adenocarcinomas
when compared with ERUS and MRI. MRI examina-
tion seems unable to recognize adenomas and should
be interpreted with care when early-stage rectal neopla-
sia is suspected.
Keywords Rectum, strain elastography, endorectal ultra-
sound, MRI, adenoma, adenocarcinoma
What does this paper add to the literature?
This paper is the first to validate elastography strain
ratio differentiation of rectal adenomas and adenocarci-
nomas. The potential risk for overtreatment of adeno-
mas and early rectal cancer following MRI assessment is
also addressed.
Introduction
Individualized treatment of rectal neoplasia is reliant
upon the accuracy of the pretreatment assessment. Ade-
nomas can be safely treated with local resection, reducing
procedure-related morbidity and mortality. Screening
programmes promote adenoma detection and therefore
accurate staging is increasingly important [1,2].
MRI for rectal neoplasia does not adequately dis-
criminate adenomas from adenocarcinomas [3]. Biopsy
sampling errors are also known to understage disease
[4,5]. Consequently, preoperative assessment may not
adequately inform treatment selection. Endorectal ultra-
sonography (ERUS) is commonly regarded as the most
accurate staging modality for rectal adenomas and early
rectal cancer. High accuracies for ERUS T-staging have
been shown by meta-analyses [6,7], but differentiation
of adenoma from carcinoma is difficult [8–12]. Up to
50% of early carcinomas may be falsely classified as ade-
nomas preoperatively [13–15].
Strain elastography is a novel method for visualiza-
tion of tissue stiffness based on the tissue’s resistance to
deformation (strain) [16,17]. Low strain is found in
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stiff tissue, indicative of malignancy. A colour map rep-
resenting tissue strain is superimposed on a B-mode
image. As the elastography algorithm is based on the
information provided by ERUS B-mode images, the
method aims to improve ERUS assessment, rather than
to replace it. Clinical application for the differentiation
of benign and malignant tumours has been validated in
several organs, including the breast [18], pancreas [19],
liver [20], prostate [21] and thyroid gland [22]. Studies
on elastography evaluation of rectal tumours are scarce
[9,23], but we have previously demonstrated the feasi-
bility of performing elastography strain ratio (SR) exam-
ination in a standard outpatient setting. An SR cut-off
value of 1.25 for the differentiation of rectal adenomas
and adenocarcinomas was also proposed based on
receiver–operating characteristics (ROC) curve analysis
[9]. Consequently, the primary aim of this study was to
perform a prospective validation of the proposed SR
cut-off value in a diverse group of rectal tumours
encountered in clinical practice. A secondary aim was to
compare the performance of elastography SR assessment
with ERUS and MRI evaluations for the differentiation
between adenomas and adenocarcinomas.
Method
Patients
One-hundred and twenty consecutive patients referred,
from 1 November 2009 to 1 April 2011, to Haukeland
University Hospital for evaluation and staging of sus-
pected rectal tumours were included. There were 67
male and 53 female patients [median age 66 (range:
25–88) years].
Histopathology evaluation of the resected specimens
revealed 21 adenomas and 99 adenocarcinomas. Sixty-
one of the 99 patients with biopsy-proven adenocarci-
noma received neoadjuvant radiotherapy. ERUS and
strain elastography were not performed (or were techni-
cally not feasible) in five adenocarcinomas, and were
consequently not assessed according to ERUS and
strain elastography protocols. MRI was not performed
in seven adenomas and five adenocarcinomas. Only
assessed tumours were included in the analysis. Conse-
quently, 94 adenocarcinomas and 21 adenomas were
assessed by ERUS and elastography SR measurements,
and 94 adenocarcinomas and 14 adenomas were
assessed by MRI. Only sessile (nonpedunculated) rectal
adenomas or adenocarcinomas with a distal border
≤ 15 cm above the anal verge, as verified by rigid recto-
sigmoidoscopy, were included. Patients with previous
rectal surgery or pelvic radiation therapy were excluded.
Informed consent was mandatory.
The ERUS and strain elastography examiner was
blinded to the results of endoscopy, biopsy and MRI. A
brief rigid rectoscopy examination was performed before
ERUS and strain elastography to verify a sufficient effect
of rectal enema and to identify the localization of the
rectal tumour. A second rectoscopy examination was
performed after the elastography examination to describe
tumour morphology and obtain biopsies if necessary.
ERUS and endorectal strain elastography
All examinations were performed by the same operator
(JERW). The patients underwent a same-session stan-
dardized clinical examination, ERUS and strain elastog-
raphy, as described previously [9]. ERUS T-stage was
assessed according to the TNM-classification system and
conclusions were recorded before strain elastography
evaluation. In five patients the ERUS and strain elastog-
raphy examinations could not be performed according
to protocol because of artefacts and/or painful examina-
tion. The ERUS evaluation was used in the multidisci-
plinary team assessment and treatment decision.
Endorectal elastography SR measurements were consid-
ered experimental and were not part of the clinical deci-
sion-making process.
We used a standard ultrasonography scanner equipped
with software for elastography (Hitachi EUB-8500, soft-
ware version: V16-04A; Hitachi Medical Corporation,
Kashiva, Japan). Both endorectal ultrasound imaging and
elastography were performed with a single rigid 360°
transrectal ultrasound probe (Hitachi EUP-R54AW-19)
with a micro convex array probe (5–10 MHz). Briefly,
the elastography method displays a colour-coded strain
map, which is superimposed on the B-mode image in real
time (Fig. 1). The semiquantification of tissue hardness is
enabled using a quasi-static autocorrelation real-time
elastography method, as previously described [9,24–26].
The strain of insonified tissues is calculated from the
frame-to-frame movement of tissue echoes under rela-
tively slow compression and decompression cycles. A
water-filled balloon connected to a syringe and covering
the ultrasound probe was used to create strain by rhyth-
mic inflation/deflation. The investigator applied pulsatile
pressure to the area of interest until a reproducible elasto-
gram was obtained.
An elastogram was defined as representative if both a
reproducible colour distribution and a constant B-mode
image were present throughout a series of ≥ 80 consecu-
tive frames. SR measurement was subsequently
performed on five representative frames, and a mean SR
was computed for statistical analysis. Tumour and refer-
ence area were selected on the B-mode image and not on
the elastogram, to avoid strain field bias and focus on the
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sono-anatomy provided by the B-mode image. The
selected areas for the SR measurements were circular and
of approximately equal size and distance from the probe
[25], representing tumour tissue (A) and reference tissue
(B). Only tissue presenting as tumour on the ERUS B-
mode image was selected for the tumour sample area,
and tissue recognized as normal rectal wall and perirectal
tissue, devoid of visible vessels or lymph nodes, was
selected for the reference sample area (Figs. 1 and 2).
MRI evaluation
Rectal MRI was performed on 1.5-T Siemens Sym-
phony or Siemens Symphony Vision, both running Syn-
go MR B17 (Siemens, Erlangen, Germany) using a
phased-array, 12-channel body coil placed on the pelvis.
In concordance with the examination protocol at Hau-
keland University Hospital, 100–150 ml of ultrasound
gel (Eco supergel; Ceracarta, Forlı, Italy) was adminis-
tered endorectally before imaging [3], in addition to
intravenous administration of 20 mg of butylsco-
polamine bromide (Buscopan; Boehringer Ingelheim,
Ingelhim am Rhein, Germany). The MRI protocol con-
sisted of sagittal, coronal and axial T2-weighted turbo
spin echo (TSE), high-resolution T2-weighted TSE and
axial T1-weighted spin-echo sequences. High-resolution
T2-weighted series were angled perpendicular to the
long axis of the rectal lesion. The slice thickness in the
high-resolution T2 series was 3 mm, with 3-mm spac-
ing indicating no gap between slices [27].
The MRI reports used in the clinical decision process
were revisited by a single experienced radiologist (CR)
for evaluation of T-stages based on the original MRI
report used in the preoperative work-up. Six patients
did not undergo MRI examination before surgery, and
eight MRI evaluations were inconclusive.
Histopathological evaluation
Transanal endoscopic microsurgery (TEM) specimens
were pinned on a plate, fixed, serially sectioned at inter-
vals of 2–3 mm and completely embedded. Rectal
resection specimens were sliced at intervals of 3–4 mm
and representative sections were selected for micros-
copy. Tissue sections were stained with haematoxylin-
eosin. All tumours receiving neoadjuvant radiation
therapy were verified by biopsy as adenocarcinomas
before radiation therapy.
Statistical analysis
An SR cut-off defining malignancy as an SR of ≥ 1.25
was derived from pilot work in a discovery set of
tumours [9]. The test validity parameters sensitivity,
Figure 1 Split-screen image shows a B-mode image with strain ratio (SR) regions of interest on the right and an elastogram on the
left. The tumour is situated from 2 to 7 o’clock (white arrow). The tumour appears softer (more red) than the same-depth refer-
ence tissue on the elastogram, and the SR (B/A) with SR measurement indicative of an adenoma (SR = 0.54) is displayed in the
upper left-hand corner. When evaluated ultrasonographically it is difficult to determine whether the tumour is an early adenocarci-
noma or an adenoma, as the hypoechoic mucosal layer is not clearly distinguished from the hyperechoic submocosal layer in the
tumour region. The resection specimen was histopathologically confirmed as adenoma.
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specificity, accuracy, negative predictive value and posi-
tive predictive value were calculated for elastography SR
evaluation, ERUS evaluation and MRI evaluation.
Histopathology of the resection specimens was used
as the reference standard
One-way ANOVA was used to test for differences in SR
values between pT-stages. The Blyth–Still–Casellas pro-
cedure was chosen to calculate the 95% CIs of test
validity parameters [28,29]. The SPSS version 21.0
(SPSS, Chicago, Illinois, USA), STATXACT 9.0 (Cytel
Software Corporation, Cambridge, Massachusetts,
USA) and Excel (Microsoft Office Excel 2003, Belle-
vue, Washington, USA) were used for data analysis.
Ethics
All patients received oral and written information,
according to the Helsinki Declaration, before signing
the consent form. The study was approved by the
Regional Committee for Medical and Health Research
Ethics of Western Norway.
Results
ERUS evaluation
The sensitivity, specificity and accuracy of ERUS evalua-
tion were 0.96, 0.62 and 0.90, respectively (Table 1).
ERUS correctly identified 76% of the adenomas and
92% of the adenocarcinomas, with corresponding rates
of false positives (24%) and false negatives (8%) when all
histologically verified adenocarcinomas were included in
the analysis.
Endorectal elastography evaluation
There was a significant difference in elastography SR
between adenomas and adenocarcinomas (P < 0.001,
one-way ANOVA), with a mean SR of 1.03 (95% CI:
0.85–1.21) for adenomas and a mean SR of 5.53 (95%
CI: 4.27–6.79) for adenocarcinomas. As demonstrated in
Fig. 3, adenocarcinomas treated with surgery alone did
not differ significantly in mean SR from those deemed eli-
gible for neoadjuvant radiotherapy (P = 0.38, one-way
ANOVA).
The predefined elastography SR cut-off level of 1.25
[9] yielded sensitivity, specificity and accuracy of 0.96,
0.86 and 0.94, respectively (Table 1). Elastography
evaluation correctly identified 82% of the adenomas and
97% of the adenocarcinomas, with corresponding rates
of false positives (18%) and false negatives (3%) when all
histologically verified adenocarcinomas were included in
the analysis.
MRI evaluation
MRI yielded sensitivity, specificity and accuracy of 0.99,
0.07 and 0.87, respectively, in separating adenomas
Figure 2 To contrast the adenoma in Fig. 1, Fig. 2 demonstrates an adenocarcinoma situated from 11 to 3 o’clock, as indicated
by the white arrow. The tumour appears harder (more blue) than the same-depth reference tissue on the elastogram, and a strain
indicative of an adenocarcinoma (SR = 5.56) is displayed in the upper left-hand corner.
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from adenocarcinomas (Table 1). MRI correctly identi-
fied one of 14 adenomas, overstaging four as mrT1,
four as mrT2, four as mrT3 and one as mrT4. A com-
parison of MRI with ERUS, strain elastography and his-
topathology is demonstrated in Fig. 4(a–d).
Discussion
Endorectal elastography assessment of rectal tumours is
a novel method yet to be properly introduced to clinical
practice. We have previously shown that it is feasible
within the constraints of a standard outpatient setting.
The current study is the first prospective study to use a
predefined SR cut-off value [9] to distinguish rectal
adenomas and adenocarcinomas. This SR assessment of
120 consecutive patients with rectal tumours confirms a
significant elastography SR difference between rectal
adenomas and adenocarcinomas (P < 0.001), and the
chosen SR cut-off value demonstrates an even higher
accuracy (0.96; 95% CI: 0.90–0.99) than previously
demonstrated. For evaluation of clinical relevance, strain
elastography was compared with ERUS and MRI
(Table 1 and Fig. 4). When comparing elastography SR
evaluation with ERUS evaluation alone, the sensitivity
Table 1 Validity parameters for evaluating elastography strain ratio, endorectal ultrasonography (ERUS) and MRI differentiation of
adenomas and adenocarcinomas.
Test validity
parameter ERUS (n = 115) Elastography (n = 115) MRI (n = 108)
Sensitivity 0.96 (0.90–0.99) 0.96 (0.90–0.99) 0.99 (0.94–1.00)
Specificity 0.62 (0.40–0.80) 0.86 (0.66–0.96) 0.07 (0.00–0.31)
Accuracy 0.90 (0.83–0.94) 0.94 (0.88–0.97) 0.87 (0.80–0.93)
PPV 0.92 (0.85–0.96) 0.97 (0.91–0.99) 0.88 (0.80–0.93)
NPV 0.76 (0.51–0.92) 0.82 (0.61–0.94) 0.50 (0.03–0.97)
Values are given as mean (95% CI), and 95% CIs were calculated using the Blyth–Still–Casella procedure.
NPV, negative predictive value; PPV, positive predictive value.
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Figure 3 Error bar chart displaying the mean strain ratio (SR) of adenomas (n = 21) and adenocarcinomas that did (n = 61) or
did not (n = 38) subsequently receive neoadjuvant radiotherapy, respectively. Adenomas were significantly different from both
groups of adenocarcinomas (P < 0.001, one-way ANOVA). The mean SR of adenocarcinomas allocated to neoadjuvant treatment
was not significantly different from that of adenocarcinomas treated with surgery alone (P = 0.38, one-way ANOVA). CRT, che-
moradiotherapy.
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was the same for both modalities; however, specificity,
accuracy, and negative- and positive-predictive values
were higher for elastography evaluation. The predictive
values suggest that adding elastography to the standard
ERUS examination could decrease the number of false-
negative adenocarcinomas from 24% to 18% and the
number of false-positive adenomas from 8% to 3%. This
suggests that strain using elastography assessment as an
add-on to ERUS assessment may improve the selection
of tumours for local resection. A study including several
low-volume institutions/examiners reporting to the UK
TEMS database demonstrated poor ERUS accuracies in
selecting rectal tumours for local resection [8].
Although not directly addressed in our study, one
might argue that the binary nature of an SR cut-off to
differentiate adenomas and adenocarcinomas is probably
easier to interpret by examiners with a low to medium
volume of ERUS examinations. Consequently, elastog-
raphy evaluation could simplify and improve selection of
patients for local treatment in an even higher percent-
age of cases than in our study.
In hospitals not performing ERUS staging, more
value in clinical decision making might be attributed to
MRI examinations as MRI probably would represent
the only imaging modality for local staging purposes. In
this context, our finding that MRI evaluation is unable
to differentiate adenomas from adenocarcinomas dem-
onstrates a potential risk for overstaging and conse-
quently overtreatment. These results are not
contradictory to those previously published, as only ver-
ified malignant tumours tend to be included [7,30–32],
and focus is frequently targeted at the ability of preop-
erative MRI to predict the need for neoadjuvant radio-
therapy. In our study, only two tumours would have
been selected for local resection based on MRI evalua-
tion alone: one adenoma and one locally advanced ade-
nocarcinoma (not suited for local resection).
Implementation of standardized protocols for acquisi-
tion and interpretation of MRI images may potentially
improve the assessment of rectal adenomas and early
rectal cancer, as demonstrated by the MERCURY
research project [33]. Assessment of factors influencing
MRI tumour evaluation was, however, beyond the
scope of this study. Consequently, our findings reflect
the actual contribution to clinical decision making of
standard MRI in a routine clinical setting.
In clinical practice one would not look at ERUS,
strain elastography or MRI in isolation, but rather as a
(a) (b)
(d)(c)
Figure 4 (a–d) Illustration of a rectal tumour situated 6–8 cm above the anal verge, from 3 to 6 o’clock (arrows). (a) Split-screen
image with an elastogram on the left, demonstrating a strain ratio (SR) measurement of 3.98 in the upper left-hand corner, indica-
tive of an adenocarcinoma. The B-mode image on the right of Fig. 4(a), in which a hypoechoic layer represents mucosa, seems to
respect the hyperechoic submucosa layer in the tumour region.
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combined approach supplementing the clinical evalua-
tion and biopsy result. However, the primary aim of this
study was to evaluate a novel method that has not been
validated previously for the assessment of rectal
tumours. Consequently, we argue that there was a need
to compare each of the methods in isolation. Figure 4
demonstrates the conflicting information with which
one might be presented in such a multimodal approach.
This underlines the need to understand the strengths
and weaknesses of each method. Consequently, future
studies should aim to assess the impact of strain elastog-
raphy evaluation on treatment decisions in clinical prac-
tice.
Although the issue of selecting patients for neoadju-
vant (chemo-) radiotherapy is solved, to a great extent,
by advances in MRI evaluation, the assessment of treat-
ment effect is still challenging. Evaluation of the radia-
tion effect was beyond the scope of this study, but this
issue is being addressed in an ongoing study. In the
current study, the elastography SR measurements were
not significantly different in adenocarcinomas eligible
for primary resection and those in need of radiation
therapy. However, a recent elastography study on the
response of radiation therapy in rectal cancer has shown
promising results [23].
Although a rigorous protocol for choosing tumour
tissue and reference tissue was designed to minimize
selection bias, all elastography examinations were per-
formed by a single examiner immediately following the
ERUS examination. As elastography SR assessment is
based on a high-quality B-mode ERUS image, which is
performed before the SR measurement by the same
observer, it may be argued that crucial information,
such as invasive tumour growth seen by ERUS, would
influence the subsequent elastography SR evaluation in
its favour, but not vice versa. Consequently, an observer
bias is possible, but the elastography method is, by
design, an add-on to B-mode ERUS. A set-up with two
observers performing separate ERUS or combined
ERUS and elastography evaluations would address this
shortcoming, but was not logistically feasible. Because
of technical limitations regarding the format of saved
elastography video loops and images, a blinded SR re-
examination was not possible, making a reliability evalu-
ation of SR measurements unattainable. Further studies
are being conducted to address some of these issues.
In conclusion, this study validates an endorectal
elastography SR of 1.25 as an accurate cut-off for the
discrimination of rectal adenomas and adenocarcino-
mas. Elastography evaluation adds precision to ERUS
and MRI examinations. Our results suggest that MRI
should be interpreted with care when adenomas or
early adenocarcinomas are suspected. Future studies
should be aimed at further clarification of the potential
role of endorectal strain elastography staging of rectal
tumours and at assessing the impact on clinical deci-
sion making.
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